In this two-year observational study, we created a Cardiovascular Risk and Reduction Learning Community consisting of DARTNet care providers and patients. We examined the electronic audit and feedback to see if this reduces major adverse cardiovascular events and their associated health care costs in patients.
This study was conducted from October 2009 through March 2012.
This project is complete. See below for key findings and publications.
Effects of Changing Guidelines on Prescribing Aspirin for Primary Prevention of Cardiovascular Events(9 page PDF). Hissett J, Folks B, Coombs L, LeBlanc W, Pace WD. J Am Board Fam Med. 2014; 27 (1):78-86.
Risk-Adjusted Comparison of Blood Pressure and Low-Density Lipoprotein (LDL) Noncontrol in Primary Care Offices.(19 page PDF) Hammermeister K, Bronsert M, Henderson WG, Coombs L, Hosokawa P, Brandt E, Bryan C, Valuck R, West DR, Liaw W, Ho M, Pace WD. J Am Board Fam Med. 2013; 26 (6):658-668.
Comparative Effectiveness in Antihypertensive Therapeutic Classes and Treatments Strategies in the Initiation of Therapy in Primary Care Patients: A Distributed Ambulatory Research in Therapeutics Network (DARTNet) Study.(10 page PDF) Bronsert MR, Henderson WG, Valuck R, et al. J Am Board Fam Med. 2013;26(5):529-38
For additional information about this study, please contact:
Elias Brandt, BA, BS
Research Systems Analyst
AAFP National Research Network
This project is funded by a grant from National Heart Lung and Blood Institute (NHLBI).
Share this page
Alert: Message field is required.
You must sign in before you can share a page on AAFP connection.
Cardiovascular Risk Reduction Learning Community In DARTNet